The global real world evidence solutions market is valued at 612.0 million in 2017 and projected to reach USD 1,348.1 million by 2023, at a CAGR of 14.3%.

The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs). The base year considered for the study is 2017 and the forecast period includes 2018 to 2023.

In this report, the Real World Evidence Solutions market has been segmented based on Component, therapeutic area, end user, and region.

What the Market Looks Like?

The Report “Real World Evidence Solutions Market by Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Immunology), End User (Pharmaceuticals, Medical Devices, Payers, Providers) - Global Forecast to 2023”

Download a FREE Pdf Brochuer@:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76173991

By component, the data sets segment accounted for the largest share of the real world evidence market in 2017.

On the basis of component, the data sets segment accounted for the largest share of the global real world evidence market. The large share can be attributed to factors such as easy availability of massive amounts of data, increasing dependence of outcome-based studies on real-world data, and rising demand for information by payers and providers regarding drug safety.

By therapeutic area, the oncology segment held the largest market share of the real world evidence market in 2017.

Based on therapeutic area, the oncology segment accounted for the largest share of the real-world evidence market in 2017. The large share of this segment can be attributed to the high number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide.

 The Major Players Opearting in the Real World Evidence Solutions Market:

Key players in the Real World Evidence Solutions Market include IQVIA (US), ICON plc (Ireland), PAREXEL International Corporation (US), Pharmaceutical Product Development, LLC (US), and Optum, Inc. (US) 

Get a FREE Request Sample Report@:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=9571619

Geographical Detailed Analysis for Real World Evidence Solutions Market:

North America accounted for the largest share of the real world evidence market in 2017, followed by Europe and Asia Pacific.

Presence of a favorable regulatory environment, high number of RWE service providers, the presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, are the major factors responsible for the large share of North America in the global real world evidence market.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: [email protected]